Biotech Values

[investorgold2002]

"unless the FDA relents."

http://www.investorcalendar.com/IC/CEPage.asp?ID=164219

Yes. Joe talks about potential flexibility with FDA wrt "substantial underway"

"we have been having several active dialogue with FDA on a question on "substantial underway"

there is flexibility beyond SPA"